UBS’s Avantax, Inc. Common Stock AVTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$463K Sell
30,351
-10,827
-26% -$179K ﹤0.01% 4357
2014
Q2
$777K Sell
41,178
-226,727
-85% -$4.27M ﹤0.01% 3792
2014
Q1
$5.28M Buy
267,905
+231,673
+639% +$5.36M ﹤0.01% 1815
2013
Q4
$1.06M Buy
36,232
+32,907
+990% +$888K ﹤0.01% 3486
2013
Q3
$77K Buy
3,325
+2,757
+485% +$57.4K ﹤0.01% 6322
2013
Q2
$11K Buy
+568
New +$9.65K ﹤0.01% 8557

Other funds holding AVTA

UBS's AVTA Position: Q3 2014 in Review

UBS reduced its Avantax, Inc. Common Stock (AVTA) stake by 26% in Q3 2014, selling an estimated $179K and leaving 30,351 shares worth $463K. The position accounts for ﹤0.01% of the portfolio, ranked #4357.

UBS first reported a position in AVTA in Q2 2013 and has held it in 6 quarters since. The position peaked at $5.28M in Q1 2014. 156 funds tracked by Wall St. Rank hold AVTA as of Q3 2014.

  • UBS held 30,351 shares of Avantax, Inc. Common Stock worth $463K as of Q3 2014.
  • UBS sold 10,827 Avantax, Inc. Common Stock shares in Q3 2014, an estimated $179K.
  • Avantax, Inc. Common Stock made up ﹤0.01% of UBS's portfolio in Q3 2014, its #4357 holding.
  • UBS first reported a position in Avantax, Inc. Common Stock in Q2 2013 and has held it in 6 quarters since.
  • UBS's Avantax, Inc. Common Stock position peaked at $5.28M in Q1 2014.
  • 156 funds tracked by Wall St. Rank held Avantax, Inc. Common Stock as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.